|
Market Closed -
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 145.55 USD | -2.23% |
|
+5.48% | +393.56% |
| 04/09 | Is the party already over for AI-boosted momentum kings? | |
| 03/09 | Evercore ISI Adjusts Moderna Price Target to $80 From $50, Maintains In Line Rating | MT |
| Market Cap | 5.81TCr 5TCr 4.7TCr 4.29TCr 8.02TCr 5,49600Cr 8.05TCr 56TCr 22TCr 2,81400Cr 22TCr 21TCr 8,96400Cr | P/E 2026 * |
-17.3x | P/E 2027 * | -29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 5.45TCr 4.68TCr 4.4TCr 4.02TCr 7.52TCr 5,15000Cr 7.54TCr 52TCr 20TCr 2,63700Cr 20TCr 20TCr 8,40100Cr | EV / Sales 2026 * |
25.9x | EV / Sales 2027 * | 22.9x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
Borsa Italiana
| 1MRNA | End-of-day quote | |
Tradegate
| 0QF | Real-time | |
Xetra
| 0QF | Delayed | |
CBOE
| Real-time | ||
Boerse Muenchen
| 0QF | Real-time | |
Mexican S.E.
| MRNA * | End-of-day quote | |
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
Börse Stuttgart
| 0QF | Delayed | |
Deutsche Boerse AG
| 0QF | Delayed | |
Wiener Boerse
| MRNA | End-of-day quote | |
CBOE
| 0A45 | Real-time | |
London S.E.
| 0A45 | Delayed | |
Lima
| MRNAUS | End-of-day quote | |
Swiss Exchange
| MRNA | Delayed | |
Swiss Exchange
| MRNA | Delayed |
Last Transcript : Moderna, Inc.
| 1 day | -2.23% | ||
| 1 week | +5.48% | ||
| Current month | +3.71% | ||
| 1 month | +170.24% | ||
| 3 months | +206.81% | ||
| 6 months | +177.13% | ||
| Current year | +393.56% |
| 1 week | 138.09 | 156.42 | |
| 1 month | 58.41 | 176.66 | |
| Current year | 29.81 | 176.66 | |
| 1 year | 22.28 | 176.66 | |
| 3 years | 22.28 | 176.66 | |
| 5 years | 22.28 | 464.85 | |
| 10 years | 11.54 | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Exercice | General Counsel | 15,793 | 0.0040% | ||
| 01/09/26 | Exercice | Chief Financial Officer | 6,147 | 0.0015% | ||
| 01/09/26 | Exercice | Chairperson | 23,055 | 0.0058% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.23% | +5.48% | +478.96% | +34.47% | 5.81TCr | ||
| -1.87% | +4.22% | +44.36% | +1.14% | 8.27TCr | ||
| -0.76% | +0.50% | -17.24% | -36.14% | 6.02TCr | ||
| +1.31% | -1.35% | -7.43% | +30.97% | 4.97TCr | ||
| -0.14% | -2.86% | +1.64% | +155.53% | 4.67TCr | ||
| -1.64% | +1.07% | +56.98% | -16.26% | 3.26TCr | ||
| -0.98% | +1.91% | +46.30% | +100.59% | 2.57TCr | ||
| -1.07% | -5.77% | -1.75% | +191.93% | 2.27TCr | ||
| -1.06% | -3.47% | +62.93% | +106.61% | 1.65TCr | ||
| -0.87% | -10.62% | -21.81% | +776.89% | 1.49TCr | ||
| Average | -0.91% | -0.45% | +64.29% | +134.57% | 4.1TCr | |
| Weighted average by Cap. | -0.98% | +0.74% | +82.69% | +69.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 210.1Cr 180.68Cr 169.94Cr 155.13Cr 290.13Cr 20TCr 291.07Cr 2.01TCr 778.85Cr 10TCr 788.99Cr 771.74Cr 32TCr | 243.77Cr 209.64Cr 197.18Cr 179.99Cr 336.63Cr 23TCr 337.72Cr 2.34TCr 903.69Cr 12TCr 915.46Cr 895.45Cr 38TCr |
| Net income | -331.26Cr -284.88Cr -267.94Cr -244.59Cr -457.45Cr -31TCr -458.93Cr -3.18TCr -1.23TCr -16TCr -1.24TCr -1.22TCr -51TCr | -194.48Cr -167.26Cr -157.31Cr -143.6Cr -268.57Cr -18TCr -269.44Cr -1.87TCr -720.97Cr -9.42TCr -730.37Cr -714.4Cr -30TCr |
| Net Debt | -365.29Cr -314.15Cr -295.47Cr -269.72Cr -504.44Cr -35TCr -506.07Cr -3.5TCr -1.35TCr -18TCr -1.37TCr -1.34TCr -56TCr | -216.92Cr -186.55Cr -175.46Cr -160.17Cr -299.55Cr -21TCr -300.52Cr -2.08TCr -804.14Cr -11TCr -814.62Cr -796.81Cr -33TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $145.55 | -2.23% | 1,49,66,547 |
| 03/26/03 | $148.87 | -1.29% | 1,32,90,379 |
| 02/26/02 | $150.81 | -2.24% | 1,65,63,188 |
| 01/26/01 | $154.27 | +9.93% | 2,58,31,743 |
| 31/26/31 | $140.34 | +1.70% | 1,85,70,704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions



















